[Pyruvate-dehydrogenase deficiency. Lethal course of the disease during infancy (author's transl)].
The course of pyruvate dehydrogenase deficiency in an infant is described. During pregnancy fetal movements were reduced, and since birth severe neurologic involvement was noticed. Permanent metabolic acidosis due to lactic acidemia as well as hyperpyruvic acidemia and hyperalaninemia were present. Alanine accumulated in CSF and urine, urinary excretion of lactate and pyruvate was highly elevated. Pyruvate dehydrogenase activity in a liver biopsy was only 5% of that for normal controls, and pyruvate decarboxylation by cultured fibroblasts was equally decreased. Therapy required permanent administration of bicarbonate. The administration of thiamine had no effect. The infant died within three months. Recently prenatal diagnosis during a subsequent pregnancy of the mother revealed normal results when pyruvate degradation with cultured amniotic fluid cells was investigated, and a healthy child was born.
D000138:Acidosis / Q000209:etiology; D000409:Alanine / Q000097:blood / Q000134:cerebrospinal fluid; D002239:Carbohydrate Metabolism, Inborn Errors / Q000175:diagnosis*; D005260:Female; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007773:Lactates / Q000097:blood / Q000652:urine; D008099:Liver / Q000201:enzymology; D011247:Pregnancy; D011296:Prenatal Diagnosis; D011768:Pyruvate Dehydrogenase Complex / Q000032:analysis; D015325:Pyruvate Dehydrogenase Complex Deficiency Disease; D011773:Pyruvates / Q000097:blood / Q000652:urine
D007773:Lactates; D011768:Pyruvate Dehydrogenase Complex; D011773:Pyruvates; D000409:Alanine
Pyruvatdehydrogenase-Mangel--letaler Verlauf im Säuglingsalter.